IGC Pharma Inc. share price logo

IGC Pharma Inc.

NASDAQ: IGC

Small Cap

$0.27

(+-0.23%)

as on

IGC Pharma Inc. Stock Performance

as on June 24, 2026 at 6:59 am IST

  • Day's High

    $0.27
    $0.29

    7.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.24
    $0.50
    downward going graph

    10.37%

    Downside

    84.63%

    Upside

    downward going graph

IGC Pharma Inc. share price movements today

Previous Close
$0.27
Open
$0.27
Volume
727.2K
Day's Low - High
$0.27 - $0.29
52 Week Low - High
$0.24 - $0.50

IGC Pharma Inc. Historical Returns

1 Month Return
-7.43 %
3 Month Return
-3.16 %
1 Year Return
-12.7 %
3 Year Return
-13.44 %
5 Year Return
-81.99 %

IGC Pharma Inc. Stock Fundamentals & Key Indicators

Check IGC Pharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.7M

EPS (TTM)

-0.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.5M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

-83.34%

IGC Pharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IGC Pharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
IGC Pharma Inc. image
IGC Pharma Inc.
BUY$26.7M-81.99%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B64.01%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B148.93%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B15.61%14.8829.65%0.59%

Stock Returns calculator for IGC Pharma Inc. Stock including INR - Dollar returns

The IGC Pharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

IGC Pharma Inc. investment value today

Current value as on today

₹95,300

Returns

-₹4,700

(-4.7%)

Returns from IGC Pharma Inc. Stock

-₹12,903 (-12.9%)

Dollar Impact

₹8,204 (+8.2%)

Analyst Recommendation on IGC Pharma Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for IGC Pharma Inc.. Average target price of $4.25

IGC Pharma Inc. Share Price Target

Get share price movements and forecasts by analysts on IGC Pharma Inc..

What analysts predicted

93.65%UPSIDE

Target Price

$4.25

Current Price

$0.27

Analyzed by

5 Analysts

Target

$4.25

IGC Pharma Inc. target price $4.25, a slight upside of 93.65% compared to current price of $0.27. According to 5 analysts rating.

Indian Investors' Interest in IGC Pharma Inc. Stock

Search interest for IGC Pharma Inc. Stock has increased by 99% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:99% versus previous 30 day period

IGC Pharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-2
-2
-1
-1
-1
-1
-2
-2
-2
EBITDA
-5
-2
-2
-1
-1
-1
-1
-1
0
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-2
-2
-1
-1
-1
-1
-1
0
-2
Income Tax Expense
-
0
-
-
-
-
-
-
-
-
Net Income
-5
-2
-2
-1
-1
-1
-1
-1
0
-2
Net Profit Margin
-2739.71%
-977.97%
-874.26%
-416.75%
-711.67%
-362.73%
-487.50%
-953.40%
-207.43%
-757.73%

IGC Pharma Inc. Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
0
2
5
4
0
0
0
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-1
-4
-6
-8
-15
-11
-9
-7
-10
EBITDA
-1
-1
-4
-6
-8
-14
-10
-12
-6
-6
Interest Expense
0
0
-
-
-
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
-
Income Before Tax
-1
-1
-4
-7
-8
-15
-11
-13
-7
-6
Income Tax Expense
0
0
0
0
0
0
0
3
-
-
Net Income
-1
-1
-4
-7
-8
-15
-11
-13
-7
-6
Net Profit Margin
-321.69%
-81.44%
-80.08%
-179.64%
-981.18%
-3782.37%
-1263.01%
-966.54%
-560.27%
-552.11%

IGC Pharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-2
-1
-1
-1
-1
-1
0
-2
Operating Cash Flow
0
-1
0
-1
0
-1
-2
-1
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
2
0
0
0
0
3
1
0
Change in Cash
0
0
0
-1
0
0
0
0
0

IGC Pharma Inc. Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-1
-4
-7
-8
-15
-11
-13
-7
-6
Operating Cash Flow
-1
-3
-8
-10
-7
-7
-5
-4
-5
Investing Cash Flow
0
0
-9
3
0
0
0
0
0
Financing Cash Flow
3
27
0
14
4
0
3
4
5
Change in Cash
1
23
-18
7
-4
-7
-1
0
0

IGC Pharma Inc. News & Key Events

    Insights on IGC Pharma Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, IGC has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 17.3% return, outperforming this stock by 30.9%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 350.0K → 317.0K (in $), with an average decrease of 9.4% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, IGC stock has moved down by -3.3%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -726.0K → -2.40M (in $), with an average decrease of 230.9% per quarter

    About IGC Pharma Inc.

    IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
    OrganisationIGC Pharma Inc.
    Headquarters10224 Falls Road, Potomac, MD, United States, 20854
    IndustryBiotechnology
    CEOMr. Ram Mukunda
    E-voting on sharesClick here to vote

    Key Management of IGC Pharma Inc.

    Name

    Title

    Mr. Ram Mukunda

    Founder, President, CEO & Director

    Ms. Claudia Grimaldi

    VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director

    Benysh Qureshi Esq., M.B.A.

    Director of Operations

    Mr. Rohit Goel CPA, M.B.A.

    Director of Accounting & Senior Director

    Susana Salgar

    Sales Manager

    FAQs

    What is IGC Pharma Inc. share price today?

    IGC Pharma Inc. share price today is $0.27 as on at the close of the market. IGC Pharma Inc. share today touched a day high of $0.29 and a low of $0.27.

    What is the 52 week high and 52 week low for IGC Pharma Inc. share?

    IGC Pharma Inc. share touched a 52 week high of $0.5 on and a 52 week low of $0.24 on . IGC Pharma Inc. stock price today i.e. is closed at $0.27,which is 45.84% down from its 52 week high and 11.57% up from its 52 week low.

    What is IGC Pharma Inc.'s market capitalisation today?

    IGC Pharma Inc. market capitalisation is $0.00T as on .

    How to invest in IGC Pharma Inc. Stock (IGC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for IGC Pharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in IGC Pharma Inc. Shares that will get you 5.5556 shares as per IGC Pharma Inc. share price of $0.27 per share as on June 24, 2026 at 1:29 am IST.

    What is the minimum amount required to buy IGC Pharma Inc. Stock (IGC) from India?

    Indian investors can start investing in IGC Pharma Inc. (IGC) shares with as little as ₹94.735 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹947.35 in IGC Pharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on IGC Pharma Inc. share’s latest price of $0.27 as on June 24, 2026 at 1:29 am IST, you will get 37.0370 shares of IGC Pharma Inc.. Learn more about fractional shares .

    What are the returns that IGC Pharma Inc. has given to Indian investors in the last 5 years?

    IGC Pharma Inc. stock has given -81.99% share price returns and 27.69% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?